| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Arrow Alexander K. is a Chief Financial Officer at Protagenic Therapeutics, Inc.\new. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $36K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 8,000 | $0.81 | $6,480.00 | +21.2% | +21.7% | -31.0% | |
| May 18, 2022 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 31,000 | $0.71 | $22,090.00 | +11.8% | -13.9% | -35.0% | |
| Apr 30, 2021 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 2,000 | $2.29 | $4,580.00 | +0.8% | -1.3% | -63.8% |